JP2001523515A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2001523515A5 JP2001523515A5 JP2000521763A JP2000521763A JP2001523515A5 JP 2001523515 A5 JP2001523515 A5 JP 2001523515A5 JP 2000521763 A JP2000521763 A JP 2000521763A JP 2000521763 A JP2000521763 A JP 2000521763A JP 2001523515 A5 JP2001523515 A5 JP 2001523515A5
- Authority
- JP
- Japan
- Prior art keywords
- insert
- caprolactone
- poly
- progestin
- mass
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical class C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 46
- 229920001610 polycaprolactone Polymers 0.000 description 46
- 239000000583 progesterone congener Substances 0.000 description 42
- 210000001215 vagina Anatomy 0.000 description 28
- 229920000642 polymer Polymers 0.000 description 22
- 241001465754 Metazoa Species 0.000 description 19
- 239000013543 active substance Substances 0.000 description 18
- 238000000034 method Methods 0.000 description 18
- 229920000858 Cyclodextrin Polymers 0.000 description 12
- 241000894007 species Species 0.000 description 12
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 11
- 239000002361 compost Substances 0.000 description 11
- 229910052710 silicon Inorganic materials 0.000 description 11
- 239000010703 silicon Substances 0.000 description 11
- 150000004676 glycans Chemical class 0.000 description 10
- 238000003780 insertion Methods 0.000 description 10
- 230000037431 insertion Effects 0.000 description 10
- 229920001282 polysaccharide Polymers 0.000 description 10
- 239000005017 polysaccharide Substances 0.000 description 10
- 241000283690 Bos taurus Species 0.000 description 9
- 239000011159 matrix material Substances 0.000 description 9
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 9
- 239000003814 drug Substances 0.000 description 8
- 229940079593 drug Drugs 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 7
- 241000124008 Mammalia Species 0.000 description 6
- 239000012190 activator Substances 0.000 description 6
- 230000014759 maintenance of location Effects 0.000 description 6
- 210000002966 serum Anatomy 0.000 description 6
- 229920002988 biodegradable polymer Polymers 0.000 description 5
- 239000004621 biodegradable polymer Substances 0.000 description 5
- 230000000717 retained effect Effects 0.000 description 5
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 4
- 102000009151 Luteinizing Hormone Human genes 0.000 description 4
- 108010073521 Luteinizing Hormone Proteins 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- 239000008101 lactose Substances 0.000 description 4
- 229940040129 luteinizing hormone Drugs 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- ODLHGICHYURWBS-LKONHMLTSA-N trappsol cyclo Chemical compound CC(O)COC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)COCC(O)C)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1COCC(C)O ODLHGICHYURWBS-LKONHMLTSA-N 0.000 description 4
- 241000283707 Capra Species 0.000 description 3
- 241000282994 Cervidae Species 0.000 description 3
- 241001494479 Pecora Species 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 239000005556 hormone Substances 0.000 description 3
- 229940088597 hormone Drugs 0.000 description 3
- 238000001746 injection moulding Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- PAPBSGBWRJIAAV-UHFFFAOYSA-N ε-Caprolactone Chemical compound O=C1CCCCCO1 PAPBSGBWRJIAAV-UHFFFAOYSA-N 0.000 description 3
- 241000283086 Equidae Species 0.000 description 2
- 239000001116 FEMA 4028 Substances 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- 239000004677 Nylon Substances 0.000 description 2
- 241000282887 Suidae Species 0.000 description 2
- 230000002745 absorbent Effects 0.000 description 2
- 239000002250 absorbent Substances 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 description 2
- 235000011175 beta-cyclodextrine Nutrition 0.000 description 2
- 229960004853 betadex Drugs 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000001186 cumulative effect Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000003623 enhancer Substances 0.000 description 2
- 230000012173 estrus Effects 0.000 description 2
- -1 for example Polymers 0.000 description 2
- 238000005755 formation reaction Methods 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 229920001778 nylon Polymers 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- 229920000728 polyester Polymers 0.000 description 2
- 239000000186 progesterone Substances 0.000 description 2
- 229960003387 progesterone Drugs 0.000 description 2
- 239000012858 resilient material Substances 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 238000010561 standard procedure Methods 0.000 description 2
- 229920001169 thermoplastic Polymers 0.000 description 2
- 239000004416 thermosoftening plastic Substances 0.000 description 2
- 241000283073 Equus caballus Species 0.000 description 1
- 229920000954 Polyglycolide Polymers 0.000 description 1
- 241000282898 Sus scrofa Species 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 238000006065 biodegradation reaction Methods 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000010408 film Substances 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 1
- 229960005375 lutein Drugs 0.000 description 1
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 description 1
- 235000012680 lutein Nutrition 0.000 description 1
- 239000001656 lutein Substances 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 239000004005 microsphere Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 229920000747 poly(lactic acid) Polymers 0.000 description 1
- 239000004633 polyglycolic acid Substances 0.000 description 1
- 239000004626 polylactic acid Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 239000004945 silicone rubber Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 1
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 1
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NZ32922997A NZ329229A (en) | 1997-11-21 | 1997-11-21 | Biodegradable intravaginal devices |
| NZ329229 | 1997-11-21 | ||
| NZ330595 | 1998-06-05 | ||
| NZ33059598 | 1998-06-05 | ||
| NZ330596 | 1998-06-05 | ||
| NZ330596A NZ330596A (en) | 1998-06-05 | 1998-06-05 | Intravaginal devices allowing for increased uptake of active ingredients |
| PCT/NZ1998/000169 WO1999026556A1 (en) | 1997-11-21 | 1998-11-23 | Biodegradable intra vaginal devices |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2001523515A JP2001523515A (ja) | 2001-11-27 |
| JP2001523515A5 true JP2001523515A5 (https=) | 2006-01-05 |
Family
ID=27353841
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000521763A Pending JP2001523515A (ja) | 1997-11-21 | 1998-11-23 | 哺乳動物の膣に挿入する装置と製造および使用方法 |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP1039843A4 (https=) |
| JP (1) | JP2001523515A (https=) |
| AU (1) | AU758858B2 (https=) |
| CA (1) | CA2311311C (https=) |
| WO (1) | WO1999026556A1 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ330596A (en) * | 1998-06-05 | 2001-02-23 | Dec Res | Intravaginal devices allowing for increased uptake of active ingredients |
| NZ337318A (en) * | 1999-08-18 | 2002-07-26 | Interag | Dispensing apparatus for dispensing same or different materials for at least two reservoirs |
| GB0009914D0 (en) | 2000-04-20 | 2000-06-07 | Metris Therapeutics Limited | Device |
| ATE455526T1 (de) * | 2000-08-24 | 2010-02-15 | Sidney Lerner | Nicht-hormonales vaginales verhütungsmittel |
| US20020106406A1 (en) * | 2000-12-08 | 2002-08-08 | Mchugh Anthony J. | Crystallizable/non-crystallizable polymer composites |
| NZ514279A (en) * | 2001-09-20 | 2004-02-27 | Ashmont Holdings Ltd | Intraruminal device for dispensing medication where device has arms that open to keep the device in the animal's rumen after a constraint device dissolves |
| US20060052341A1 (en) * | 2002-02-08 | 2006-03-09 | Brian Cornish | Control of a biological function |
| WO2004091570A1 (en) * | 2003-04-17 | 2004-10-28 | Interag | Method of treatment |
| JP2023508606A (ja) * | 2019-12-23 | 2023-03-02 | オーガスタ ユニバーシティ リサーチ インスティチュート，インコーポレイテッド | 排卵を誘発し、黄体期支持を提供するプロゲステロン製剤 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4732763A (en) * | 1978-10-17 | 1988-03-22 | Stolle Research And Development Corporation | Active/passive immunization of the internal female reproductive organs |
| US5116619A (en) * | 1988-08-30 | 1992-05-26 | Lee Roy Morgan | Vaginal progesterone tablet |
| US4938763B1 (en) * | 1988-10-03 | 1995-07-04 | Atrix Lab Inc | Biodegradable in-situ forming implants and method of producing the same |
| NZ228382A (en) * | 1989-03-17 | 1992-08-26 | Carter Holt Harvey Plastic Pro | Drug administering coil-like device for insertion in body cavity of animal |
| US5518730A (en) * | 1992-06-03 | 1996-05-21 | Fuisz Technologies Ltd. | Biodegradable controlled release flash flow melt-spun delivery system |
| GB9605857D0 (en) * | 1996-03-20 | 1996-05-22 | Tester Richard F | Polysaccharides as chemical release systems |
| NZ286492A (en) | 1996-05-01 | 1998-02-26 | Dec International Nz Ltd Subst | Intra vaginal devices for synchronising oestrus of animals is made up of cured silicone rubber material with 5% by weight of progesterone |
| CN1193718C (zh) * | 1997-05-28 | 2005-03-23 | 英特瑞格 | 猪用阴道内器具及其使用方法 |
-
1998
- 1998-11-23 CA CA002311311A patent/CA2311311C/en not_active Expired - Fee Related
- 1998-11-23 JP JP2000521763A patent/JP2001523515A/ja active Pending
- 1998-11-23 AU AU16962/99A patent/AU758858B2/en not_active Ceased
- 1998-11-23 WO PCT/NZ1998/000169 patent/WO1999026556A1/en not_active Ceased
- 1998-11-23 EP EP98961699A patent/EP1039843A4/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU777673B2 (en) | Enhanced intra vaginal devices | |
| US3887699A (en) | Biodegradable polymeric article for dispensing drugs | |
| US5543156A (en) | Bioerodible devices and compositions for diffusional release of agents | |
| US9833548B2 (en) | Methods and compositions for treating post-operative pain comprising clonidine | |
| DE3853853T2 (de) | Verabreichungsformen für Pharmaka. | |
| US20060067973A1 (en) | Bone void filler | |
| CN101842099A (zh) | 包括局部麻醉药的治疗术后痛的方法和组合物 | |
| JPS642120B2 (https=) | ||
| EP0788340A1 (en) | Controlled release container with core and outer shell | |
| WO1997040776A1 (en) | Synchronising of animal oestrus and intra vaginal devices useful therein | |
| AU2002235050B2 (en) | Geometry retainable devices for body cavities | |
| US20060051391A1 (en) | Device for the controlled administration of substances to be inserted in a body cavity | |
| AU2002235050A1 (en) | Geometry retainable devices for body cavities | |
| JP2001523515A5 (https=) | ||
| JP2011508791A (ja) | 生物分解性ポリマー担体中のフルオシノロン製剤 | |
| CA2311311C (en) | Biodegradable intra vaginal devices | |
| JP2009526093A (ja) | ポリマー埋込物およびポリマー埋込物を得るための方法 | |
| NZ329229A (en) | Biodegradable intravaginal devices | |
| Ogle | Design, development and optimisation of veterinary intravaginal controlled release drug delivery systems | |
| AU743947B3 (en) | Synchronising of animal oestrus and intra vaginal devices useful therein | |
| AU776329B2 (en) | Synchronising of animal oestrus and intra vaginal devices useful therein | |
| Alashetty | Histopathological Changes At Subdermal Region Due To Subdermal Biodegradable Polymer Implant An Experimental Study | |
| CA2438127A1 (en) | Geometry retainable devices for body cavities |